- Report
- April 2026
- 211 Pages
Australia
From €4415EUR$4,850USD£3,804GBP
- Report
- April 2026
- 212 Pages
Brazil
From €4415EUR$4,850USD£3,804GBP
- Report
- April 2026
- 213 Pages
Canada
From €4415EUR$4,850USD£3,804GBP
- Report
- April 2026
- 214 Pages
Germany
From €4415EUR$4,850USD£3,804GBP
- Report
- April 2026
- 215 Pages
India
From €4415EUR$4,850USD£3,804GBP
- Report
- April 2026
- 216 Pages
Indonesia
From €4415EUR$4,850USD£3,804GBP
- Report
- April 2026
- 217 Pages
Italy
From €4415EUR$4,850USD£3,804GBP
- Report
- April 2026
- 218 Pages
Japan
From €4415EUR$4,850USD£3,804GBP
- Report
- April 2026
- 219 Pages
Malaysia
From €4415EUR$4,850USD£3,804GBP
- Report
- April 2026
- 220 Pages
Mexico
From €4415EUR$4,850USD£3,804GBP
- Report
- April 2026
- 221 Pages
Netherlands
From €4415EUR$4,850USD£3,804GBP
- Report
- April 2026
- 222 Pages
China
From €4415EUR$4,850USD£3,804GBP
- Report
- April 2026
- 223 Pages
Saudi Arabia
From €4415EUR$4,850USD£3,804GBP
- Report
- April 2026
- 224 Pages
South Africa
From €4415EUR$4,850USD£3,804GBP
- Report
- April 2026
- 225 Pages
South Korea
From €4415EUR$4,850USD£3,804GBP
- Report
- April 2026
- 226 Pages
Spain
From €4415EUR$4,850USD£3,804GBP
- Report
- April 2026
- 227 Pages
Thailand
From €4415EUR$4,850USD£3,804GBP
- Report
- April 2026
- 228 Pages
Turkey
From €4415EUR$4,850USD£3,804GBP
- Report
- April 2026
- 229 Pages
United Kingdom
From €4415EUR$4,850USD£3,804GBP
- Report
- April 2026
- 162 Pages
Canada
From €4415EUR$4,850USD£3,804GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more